Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.08.26

ACS Green Chemistry Institute Pharmaceutical Roundtable

Sai Life Sciences joins the ACS Green Chemistry Institute Pharmaceutical Roundtable

Sai Life Sciences today announced its induction to the ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’. The company has been committed to increasing the adoption of Green Chemistry principles in its process development and instituted its inaugural ‘Green Chemistry Awards’ last year, to recognize and celebrate teams that make notable contributions towards greener processes. Joining the ACS-GCIPR will allow the company to interact with large pharma and other CDMOs to further share and develop best practices in Green chemistry and sustainability

Welcoming Sai Life Sciences into its fold, an ACS-GCIPR spokesperson said, “The ACS GCI Roundtable is delighted to welcome Sai Life Sciences into its membership. As one of a few CDMO companies in our membership, their enthusiasm in catalysing the integration of green chemistry and engineering in the pharmaceutical industry is another heartening sign that adoption of Green Chemistry principles is indeed gaining momentum. We look forward to their active participation in the important work of the roundtable.”

Established in 2005 by the American Chemical Society’s Green Chemistry Institute, the Pharmaceutical Roundtable’s activities are driven by the shared belief that green chemistry and engineering is imperative for business and environmental sustainability. Its member companies come together to catalyse innovative approaches to improving process efficiency and product quality through green chemistry and engineering.

Over the past 18 months, Sai Life Sciences has made several enhancements to its HSE practices as part of the org-wide transformation initiative, Sai Nxt. Earlier this year, it became the first India-headquartered company to join the PSCI membership. The company also received 5-Star rating for Excellence in EHS Practices at the Confederation of Indian Industry (CII) South awards 2019. It operates a Zero Liquid Discharge cGMP manufacturing site in Bidar, India and has achieved zero waste to landfill.

Share article

More News

2026.04.06

Sai Life Sciences recognized as Best Organization for Women (BOW) 2026 by ET Edge

Sai Life Sciences has been recognized as a Best Organization for Women (BOW) 2026 by ET Edge, reinforcing its continued commitment to fostering an inclusive, supportive, and empowering workplace for women. This recognition reflects the organization’s sustained efforts to build an environment where women can thrive—both professionally and personally. At Sai, these efforts are anchored […]
Read more

2026.03.27

Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development

In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a model for accelerating drug discovery and development through true scientific integration.In the article, Dr. B.V.N.B.S. Sarma, Senior Vice President – Discovery, highlights how co-locating multidisciplinary teams—from medicinal chemistry and biology to DMPK, developability, process development, […]
Read more

2026.03.27

Sai Life Sciences hosts Biotech Pitch Day 2026 at Boston Site

Sai Life Sciences successfully hosted its Biotech Pitch Day 2026 at its Boston-area site on March 19, bringing together a dynamic group of emerging biotech innovators, scientific leaders, and industry experts. The event was designed as a platform for early-stage biotech companies to showcase their science, strengthen visibility, and engage with potential collaborators across the […]
Read more

2026.03.25

Kudikunta Lake restoration completed, marking the revival of an urban water body

Kudikunta Lake in Kondapur, Hyderabad, was inaugurated on February 28th following the completion of restoration efforts undertaken by Sai Life Sciences as part of its Corporate Social Responsibility (CSR) initiative in collaboration with the Society for Advancement of Human Endeavour (SAHE). The event marked the culmination of several months of work to restore a previously […]
Read more

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more